Novo Nordisk and ORA have officially sealed a groundbreaking partnership that aims to transform obesity care across the Philippines. By leveraging Novo Nordisk’s renowned clinical expertise and ORA’s cutting-edge, fully digital care platform, this collaboration promises to deliver end-to-end obesity management—from virtual consultations to personalized treatment plans and convenient medication delivery—all from the comfort of home.

Obesity care in the Philippines often faces hurdles such as stigma, high costs, and limited access to qualified medical professionals. Novo Nordisk and ORA’s joint initiative seeks to break down these barriers, empowering Filipinos to take control of their health. Through telehealth, patients can now access quality consultations and science-based treatment plans, while overcoming social and logistical challenges historically associated with obesity care.

ORA’s fully digital care platform is at the heart of this transformation. Patients can seamlessly book virtual consultations, receive customized care plans, and have prescribed medications delivered directly to their door. Combined with Novo Nordisk’s decades of clinical leadership in treating obesity, this partnership sets a new benchmark for accessible, stigma-free, and patient-centered obesity management in the country.

This initiative forms part of Novo Nordisk’s Truth About Weight (TAW) campaign in the Philippines. TAW is dedicated to raising awareness about obesity, dismantling harmful misconceptions and stigmas, and encouraging informed, science-based approaches to weight management. Through education and accessible care, the campaign hopes to empower Filipinos to make confident, long-term decisions about their health.

The official partnership was marked with a signing event, attended by prominent figures from both organizations. Pictured are Thalia Bondoc, Director for Marketing, ORA; Tom Reynolds, Vice President for Marketing, ORA; Wei Sun, General Manager, Novo Nordisk Philippines; and Geraldine Perez, Market Access & Business Development Director, Novo Nordisk Philippines. They were joined by key colleagues from both Novo Nordisk Philippines and ORA, whose collaboration made this innovative alliance possible.

Together, Novo Nordisk and ORA are mapping a new future for obesity care—one where every Filipino can access expert advice and compassionate care, wherever they are.